SECreport
Form 8-K OPIANT PHARMACEUTICALS, For: Aug 29
Last opiant pharmaceuticals earnings: 8/9 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: ir.opiant.com/investor-overview
| IMPACT SNAPSHOT | EVENT TIME: | OPNT | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
OPNT alerts
OPNT alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPNT alerts
High impacting OPIANT PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics
OPNT
NEWS
NEWS
- Opiant Pharmaceuticals' OPNT005 receives grant for development of a heroin vaccine [Seeking Alpha][Seeking Alpha]
- Opiant Pharmaceuticals Announces Receipt of National Institutes of Health Grant by Walter Reed Army Institute of Research and SUNY Upstate Medical University for Development of a Heroin Vaccine[GlobeNewswire]
- Opiant Pharmaceuticals Inc (NASDAQ: OPNT) was given a new $42.00 price target on by analysts at Cantor Fitzgerald. They now have a "buy" rating on the stock.[MarketBeat]
- Opiant Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares[GlobeNewswire]
- Opiant Pharmaceuticals Inc (NASDAQ: OPNT) was given a new $42.00 price target on by analysts at Cantor Fitzgerald. They now have a "buy" rating on the stock.[MarketBeat]
- More
OPNT
SEC Filings
SEC Filings
- 10/10/18 - Form 4
- 10/9/18 - Form SC
- 10/9/18 - Form SC
- OPNT's page on the SEC website
- More